SCHEMBL7254516

SCHEMBL7254516

COC(=O)Cc1ccccc1Oc1ccc(OC)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.56
SLC6A2 P23975 1/20 0.56
SLC6A3 Q01959 1/20 0.56
L3MBTL1 Q9Y468 5/20 0.54
TDP1 Q9NUW8 3/20 0.54
ALDH1A1 P00352 3/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
SLC1A5 Q15758 1/20 0.50
TSHR P16473 1/20 0.50
ATM Q13315 2/20 0.48
GAA P10253 2/20 0.48
LMNA P02545 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MMP2 P08253 2/20 0.46
MMP9 P14780 2/20 0.46
MMP8 P22894 2/20 0.46
MMP12 P39900 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL837233 0.90 RIPK1 (0.51) SLC6A4SLC6A2L3MBTL1TDP1ALDH1A1
SCHEMBL6935863 0.89 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3L3MBTL1TDP1
SCHEMBL10093148 0.88 SLC6A4 (0.43) SLC6A4SLC6A2SLC6A3L3MBTL1TDP1
SCHEMBL2248000 0.88 HTR2A (0.60) SLC6A4SLC6A2SLC6A3L3MBTL1ALDH1A1
SCHEMBL8002569 0.87 MTNR1B (0.54) L3MBTL1TDP1ALDH1A1MEN1KMT2A
SCHEMBL9151951 0.85 MTNR1B (0.53) ALDH1A1MEN1KMT2ASLC1A5TSHR
SCHEMBL9042004 0.85 ALDH1A1 (0.45) SLC6A4SLC6A2SLC6A3L3MBTL1TDP1
SCHEMBL9150938 0.84 KDM4E (0.48) SLC6A4SLC6A2ALDH1A1MEN1KMT2A
SCHEMBL6179348 0.84 CAMK2A (0.54) ALDH1A1MEN1KMT2AHPGDPOLB
SCHEMBL30027909 0.83 MEN1 (0.58) L3MBTL1TDP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030166725-A1 Compounds active at the glucocorticoid receptor KARO BIO AB (SE) 2003-09-04 US disclosed
EP-1265839-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2002-12-18 EP disclosed
WO-2001047859-A1 COMPOUNDS ACTIVE AT THE GLUCOCORTICOID RECEPTOR KARO BIO AB (SE) 2001-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166725-A1 Compounds active at the glucocorticoid receptor NR3C1, NR3C2, GPR119 SLC6A4 1818/4885SLC6A2 1599/4885SLC6A3 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.